NGS-Based RNA-Seq System : The Coming Revolution in Digital Health
SummaryGlobal NGS- based RNA- seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS- based RNA- seq market, in the coming years.
- Author Name: anushree
This research report is equipped with the information categorising for NGS-based RNA-seq System Market by parameters such as players, brands, regions, types and application. The report also details the information about the global market status, competition landscape, growth rate, future trends, market drivers, challenges, opportunities and porter’s forces analysis with respect to these elements.
According to a new market research study titled ‘NGS- Based RNA- Seq Market to 2027 - Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS- based RNA- seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027.The report highlights the trends prevalent in the global NGS- based RNA- seq market and the factors driving the market along with those that act as deterrents to its growth.
Leading NGS-Based RNA-Seq System Market Players:
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Pacific Biosciences of California, Inc.
- F, Hoffman-La Roche Ltd
- Agilent Technologies
- Oxford Nanopre Technologies
- Eurofins Scientific
- Perkinelmer Inc.
On the basis of end user, the NGS-based RNA sequencing market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. In 2018, the research centers segment held a largest market share of 45.0% of the genomics market, by end user. This segment is also expected to dominate the market in 2027. However, the hospitals & clinics segment is anticipated to witness the fastest growth rate of 23.2% during the forecast period, 2018 to 2027. This higher growth rate of the segment owing to the providing the references for further researches are likely to propel the growth of the research centers and academic & government institutes segment in the coming future
The target audience for the report on the NGS-Based RNA-Seq System market
- Market analysts
- Senior executives
- Business development managers
- R&D staff
- Equity research firms
NGS-BASED RNA SEQUENCING – MARKET SEGMENTATION
- Sample Preparation
- Manual Method
- Automated Method
- Workflow Step
- Library Preparation & Target Enrichment
- Fragmentation, End Repair & Size Selection
- Quality Control
- Sequencing Services
- Sequencing Platform & Consumables
- Data Analysis, Storage & Management
- Sequencing By Synthesis
- Nanopore Sequencing
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Drug Discovery
- Precision Medicine
By End User
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Biotechnology & Pharmaceutical Companies
- North America
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- South America (SAM)
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.